900
Participants
Start Date
May 19, 2017
Primary Completion Date
April 8, 2019
Study Completion Date
April 8, 2019
Clinical Recommendations
"The clinical recommendations will regard the following:~1. Avoidance of potentially nephrotoxic medications (e.g. NSAIDs, intravascular contrast, nephrotoxic antimicrobials)~2. Optimizing volume status (avoidance of volume overload or depletion)~3. Optimizing electrolytes and acid-base status~4. Optimizing hemodynamics (Mean arterial BP\>65mmHg)~5. Assessment of kidney function with serum creatinine and/or cystatin C~None of the suggestions will be experimental. All suggestions will be based on standard nephrology practice."
Mayo Clinic in Florida, Jacksonville
Mayo Clinic in Rochester, Rochester
Mayo Clinic in Arizona, Scottsdale
Lead Sponsor
Mayo Clinic
OTHER